Worsening anemia predicts end-stage renal disease (ESRD) in patients with type 2 diabetes and nephropathy

被引:0
作者
Mohanram, A
Zhang, ZX
Shahinfar, S
Keane, W
Brenner, BM
Toto, RD
机构
[1] Univ Texas, SW Med Ctr, Dallas, TX USA
[2] Merck & Co Inc, W Point, PA USA
[3] Brigham & Womens Hosp, Boston, MA 02115 USA
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
75
引用
收藏
页码:A33 / A33
页数:1
相关论文
共 50 条
[21]   Stereopsis in end-stage renal disease (ESRD) [J].
Jones, Daniel J. W. ;
Harris, John P. ;
Butler, Laurie T. ;
Vaux, Emma C. .
PHYSIOLOGY & BEHAVIOR, 2017, 171 :1-6
[22]   Losartan and the United States costs of end-stage renal disease by baseline albuminuria in patients with type 2 diabetes and nephropathy [J].
Alexander, CM ;
Lyle, PA ;
Keane, WF ;
Carides, GW ;
Zhang, ZX ;
Shahinfar, S .
KIDNEY INTERNATIONAL, 2004, 66 :S115-S117
[23]   The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: Lessons from the RENAAL study [J].
Keane, WF ;
Brenner, BM ;
De Zeeuw, D ;
Grunfeld, JP ;
McGill, J ;
Mitch, WE ;
Ribeiro, AB ;
Shahinfar, S ;
Simpson, RL ;
Snapinn, SM ;
Toto, R .
DIABETES, 2002, 51 :A185-A185
[24]   Death, end-stage renal disease and renal function decline in patients with diabetic nephropathy in French cohorts of type 1 and type 2 diabetes [J].
Samy Hadjadj ;
Bertrand Cariou ;
Frederic Fumeron ;
Elise Gand ;
Guillaume Charpentier ;
Ronan Roussel ;
Ahmed-Amine Kasmi ;
Jean-François Gautier ;
Kammel Mohammedi ;
Pierre Gourdy ;
Pierre-Jean Saulnier ;
Eva Feigerlova ;
Michel Marre .
Diabetologia, 2016, 59 :208-216
[25]   Death, end-stage renal disease and renal function decline in patients with diabetic nephropathy in French cohorts of type 1 and type 2 diabetes [J].
Hadjadj, Samy ;
Cariou, Bertrand ;
Fumeron, Frederic ;
Gand, Elise ;
Charpentier, Guillaume ;
Roussel, Ronan ;
Kasmi, Ahmed-Amine ;
Gautier, Jean-Francois ;
Mohammedi, Kammel ;
Gourdy, Pierre ;
Saulnier, Pierre-Jean ;
Feigerlova, Eva ;
Marre, Michel .
DIABETOLOGIA, 2016, 59 (01) :208-216
[26]   EFFECTS OF ERYTHROPOIETIN (EPOCH) ON NEUROPSYCHOLOGICAL FUNCTION IN PATIENTS WITH ANEMIA OF END-STAGE RENAL-DISEASE (ESRD) [J].
KLEIN, WL ;
FREDERICKSON, ED ;
FENNELL, EB ;
PETERSON, JC ;
GUZMAN, SH ;
TISHER, CC .
CLINICAL RESEARCH, 1989, 37 (02) :A493-A493
[27]   Incidence of End-Stage Renal Disease in Patients With Type 1 Diabetes [J].
Helve, Jaakko ;
Sund, Reijo ;
Arffman, Martti ;
Harjutsalo, Valma ;
Groop, Per-Henrik ;
Gronhagen-Riska, Carola ;
Finne, Patrik .
DIABETES CARE, 2018, 41 (03) :434-439
[28]   Incidence of end-stage renal disease in patients with type 1 diabetes [J].
Finne, P ;
Reunanen, A ;
Stenman, S ;
Groop, PH ;
Grönhagen-Riska, C .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (14) :1782-1787
[29]   Risk of end-stage renal disease in patients with type 1 diabetes [J].
Finne, P ;
Reunanen, A ;
Groop, PH ;
Grönhagen-Riska, C .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 :V241-V241
[30]   Serum Vascular Adhesion Protein-1 Predicts End-Stage Renal Disease in Patients with Type 2 Diabetes [J].
Li, Hung-Yuan ;
Lin, Hung-An ;
Nien, Feng-Jung ;
Wu, Vin-Cent ;
Jiang, Yi-Der ;
Chang, Tien-Jyun ;
Kao, Hsien-Li ;
Lin, Mao-Shin ;
Wei, Jung-Nan ;
Lin, Cheng-Hsin ;
Shih, Shyang-Rong ;
Hung, Chi-Sheng ;
Chuang, Lee-Ming .
PLOS ONE, 2016, 11 (02)